BRIGHTPATH BIOTHERAPEUTICS CO., LTD. · ブライトパス.バイオ株式会社
Last · —$43.000.00 (0.00%)live · yahoo · 1h ago
Market cap——
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | ¥155.8M |
|---|---|
| Operating income | ¥-1.7B |
| Net income | ¥-1.9B |
| Free cash flow | ¥-1.6B |
| Operating margin | -1069.0% |
| Net margin | -1209.4% |
| Return on equity | -37.5% |
| Period | 2019 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-06-25
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.6 years
- Accumulated Deficit High — Accumulated deficit / equity 216%
- Rd Intensity High — R&D/Revenue 1193444.0%
Documents
FormReporting forFiledFlags